We are live on ! Find out more
GCM

Graham Capital Management Portfolio holdings

AUM $4.14B
1-Year Est. Return 17.82%
This Fund
S&P 500
This Quarter Est. Return
+4.83%
1 Year Est. Return
+17.82%
3 Year Est. Return
+41.13%
5 Year Est. Return
+43.39%
10 Year Est. Return
+274.46%
AUM
$5.81B
AUM Growth
+$1.21B
Cap. Flow
-$111M
Cap. Flow %
-1.92%
Top 10 Hldgs %
50.93%
Holding
1,403
New
403
Increased
294
Reduced
341
Closed
336

Top Sells

Rank Stock Value
1
MSTR icon
Strategy Inc
MSTR
+$59.8M
2
KO icon
Coca-Cola
KO
+$16M
3
STT icon
State Street
STT
+$14M
4
TMO icon
Thermo Fisher Scientific
TMO
+$13.3M
5
CMS icon
CMS Energy
CMS
+$11.4M

Sector Composition

Rank Sector Weight
1 Technology 5.72%
2 Industrials 4.29%
3 Financials 3.7%
4 Consumer Discretionary 2.83%
5 Healthcare 2.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARDX icon
876
Ardelyx
ARDX
$1B
$208K ﹤0.01%
30,139
-12,392
-29% -$73.1K
SFIX
877
Stitch Fix
SFIX
$546M
$208K ﹤0.01%
+73,593
New +$286K
ARQT icon
878
Arcutis Biotherapeutics
ARQT
$3.24B
$207K ﹤0.01%
22,286
-43,879
-66% -$433K
GTY
879
Getty Realty Corp
GTY
$2.03B
$207K ﹤0.01%
+6,511
New +$199K
PLGO
880
Pelagos Insurance Capital
PLGO
$2.12B
$207K ﹤0.01%
+11,457
New +$202K
DCGO icon
881
DocGo
DCGO
$58.6M
$205K ﹤0.01%
61,783
-20,218
-25% -$68.7K
CRSP icon
882
CRISPR Therapeutics
CRSP
$5.26B
$205K ﹤0.01%
4,358
-951
-18% -$48.3K
PFG icon
883
Principal Financial Group
PFG
$24.4B
$205K ﹤0.01%
+2,383
New +$192K
PSN icon
884
Parsons
PSN
$4.97B
$204K ﹤0.01%
1,968
-3,481
-64% -$312K
HAIN icon
885
Hain Celestial
HAIN
$53.7M
$204K ﹤0.01%
23,617
-76,352
-76% -$572K
PLMR icon
886
Palomar
PLMR
$3.45B
$204K ﹤0.01%
+2,150
New +$198K
FWONK icon
887
Liberty Media Series C
FWONK
$25.7B
$203K ﹤0.01%
+2,623
New +$202K
EW icon
888
Edwards Lifesciences
EW
$53.1B
$202K ﹤0.01%
+3,061
New +$222K
DX
889
Dynex Capital
DX
$3.18B
$202K ﹤0.01%
15,821
+3,182
+25% +$39.3K
EFX icon
890
Equifax
EFX
$21.4B
$201K ﹤0.01%
685
-1,617
-70% -$456K
PAYO icon
891
Payoneer
PAYO
$2.41B
$200K ﹤0.01%
26,621
-41,865
-61% -$272K
SKIN icon
892
SkinHealth Systems
SKIN
$83.7M
$200K ﹤0.01%
139,070
-59,111
-30% -$96.9K
GATO
893
DELISTED
Gatos Silver, Inc.
GATO
$200K ﹤0.01%
13,268
-3,994
-23% -$51.2K
CNDT icon
894
Conduent
CNDT
$237M
$200K ﹤0.01%
49,554
+30,026
+154% +$110K
DRD
895
DRDGold
DRD
$2.04B
$200K ﹤0.01%
20,716
-5,202
-20% -$48.1K
EOLS icon
896
Evolus
EOLS
$495M
$195K ﹤0.01%
12,056
-5,138
-30% -$71.8K
OSG
897
Octave Specialty Group
OSG
$213M
$195K ﹤0.01%
+17,361
New +$203K
OFIX icon
898
Orthofix Medical
OFIX
$418M
$193K ﹤0.01%
+12,386
New +$198K
NEWT icon
899
NewtekOne
NEWT
$381M
$193K ﹤0.01%
+15,525
New +$197K
GTX icon
900
Garrett Motion
GTX
$5.51B
$193K ﹤0.01%
+23,640
New +$199K

Similar funds

Graham Capital Management's Q3 2024 Portfolio in Review

As of Q3 2024, Graham Capital Management held 1,403 positions worth $5.81B, up 26% from $4.6B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Graham Capital Management's Q3 2024 filing shows 403 new, 294 increased, 341 reduced and 336 closed positions. Its largest new stake was VanEck Gold Miners ETF: 554,036 shares worth $22.1M. The largest sale was Strategy Inc, an estimated $59.8M.

By sector, the portfolio is most concentrated in Technology at 5.7% of assets, down from 6.7% a quarter earlier, followed by Industrials and Financials.

  • Graham Capital Management's largest Q3 2024 buy was VanEck Gold Miners ETF: 554,036 shares worth $22.1M.
  • Graham Capital Management added most to iShares Bitcoin Trust in Q3 2024, an estimated $37.1M increase.
  • Graham Capital Management's biggest Q3 2024 reduction was State Street, cutting an estimated $14M.
  • Graham Capital Management fully exited Strategy Inc in Q3 2024, selling an estimated $59.8M.
  • Graham Capital Management's ten largest holdings make up 51% of its $5.81B portfolio in Q3 2024.
  • Graham Capital Management opened 403 new positions and closed 336 in Q3 2024.
  • Graham Capital Management's portfolio value rose 26% quarter-over-quarter to $5.81B.

Based on Graham Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.